Total Payments
$3,797
2024 Payments
$335.17
Companies
29
Transactions
177
Medicare Patients
22,168
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$3,797 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,797 | 177 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $828.54 | 51 | $0 (2024) |
| Abbott Laboratories | $598.07 | 19 | $0 (2023) |
| Gilead Sciences, Inc. | $489.44 | 23 | $0 (2018) |
| Medtronic, Inc. | $362.43 | 5 | $0 (2024) |
| Medtronic Vascular, Inc. | $218.96 | 9 | $0 (2020) |
| Boston Scientific Corporation | $171.81 | 7 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $137.59 | 9 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $113.56 | 8 | $0 (2023) |
| PFIZER INC. | $112.01 | 7 | $0 (2024) |
| Amgen Inc. | $100.37 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $335.17 | 12 | Medtronic, Inc. ($139.61) |
| 2023 | $497.50 | 17 | Medtronic, Inc. ($189.97) |
| 2022 | $330.29 | 19 | Novartis Pharmaceuticals Corporation ($128.58) |
| 2021 | $267.94 | 16 | Novartis Pharmaceuticals Corporation ($118.45) |
| 2020 | $298.13 | 15 | Novartis Pharmaceuticals Corporation ($68.76) |
| 2019 | $400.23 | 17 | Abbott Laboratories ($159.67) |
| 2018 | $701.84 | 32 | Gilead Sciences, Inc. ($198.86) |
| 2017 | $965.98 | 49 | Gilead Sciences Inc ($290.58) |
All Payment Transactions
177 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/08/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $139.61 | General |
| Category: Pacemakers | ||||||
| 08/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.60 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/24/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $1.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2023 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $92.04 | General |
| Category: Transcatheter Valve Systems | ||||||
| 10/11/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.44 | General |
| Category: Cardiovascular | ||||||
| 09/25/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/11/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Diabetes | ||||||
| 08/31/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Diabetes | ||||||
| 08/22/2023 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Genetic Disease | ||||||
| 08/18/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/12/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/07/2023 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: LUX-Dx_CRM | ||||||
| 06/07/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/11/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/08/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 6,105 | 8,152 | $1.5M | $573,393 |
| 2022 | 28 | 5,855 | 8,123 | $1.5M | $576,676 |
| 2021 | 30 | 5,404 | 7,129 | $1.3M | $546,778 |
| 2020 | 35 | 4,804 | 6,449 | $1.1M | $438,583 |
Total Patients
22,168
Total Services
29,853
Medicare Billing
$2.1M
Procedure Codes
140
All Medicare Procedures & Services
140 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 381 | 382 | $458,400 | $134,190 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 990 | 1,232 | $224,224 | $111,683 | 49.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 269 | 282 | $153,818 | $42,234 | 27.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 211 | 300 | $60,600 | $40,146 | 66.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 212 | 848 | $50,880 | $35,197 | 69.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 220 | 227 | $95,340 | $32,989 | 34.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 195 | 195 | $49,140 | $31,731 | 64.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 130 | 151 | $36,542 | $20,492 | 56.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 381 | 383 | $77,749 | $19,174 | 24.7% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 378 | 390 | $28,104 | $18,857 | 67.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,284 | 1,726 | $74,218 | $18,777 | 25.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 127 | 270 | $38,340 | $16,945 | 44.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 206 | 210 | $37,800 | $11,388 | 30.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 58 | $9,744 | $5,526 | 56.7% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 99 | 103 | $25,853 | $5,496 | 21.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 561 | 668 | $13,360 | $4,383 | 32.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 31 | 33 | $6,666 | $3,646 | 54.7% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 17 | 91 | $4,914 | $2,789 | 56.8% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 48 | 140 | $4,620 | $2,167 | 46.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 37 | 106 | $4,452 | $2,082 | 46.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 25 | 34 | $2,992 | $1,914 | 64.0% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 18 | 18 | $5,076 | $1,585 | 31.2% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Office | 2023 | 17 | 25 | $2,225 | $1,451 | 65.2% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 22 | 32 | $2,272 | $1,366 | 60.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 16 | $2,912 | $1,216 | 41.8% |
About Dr. David Yu, M.D
Dr. David Yu, M.D is a Cardiovascular Disease healthcare provider based in Frederick, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861497646.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Yu, M.D has received a total of $3,797 in payments from pharmaceutical and medical device companies, with $335.17 received in 2024. These payments were reported across 177 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,797).
As a Medicare-enrolled provider, Yu has provided services to 22,168 Medicare beneficiaries, totaling 29,853 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 140 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Frederick, MD
- Active Since 06/17/2005
- Last Updated 03/31/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1861497646
Products in Payments
- ENTRESTO (Drug) $720.66
- Ranexa (Drug) $234.68
- Confirm Rx (Device) $214.67
- COREVALVE EVOLUT R (Device) $189.97
- WATCHMAN (Device) $151.82
- MICRA (Device) $139.61
- XARELTO (Drug) $137.59
- MRI Ready Leads (Device) $127.62
- MULTAQ (Drug) $113.56
- LEQVIO (Drug) $90.67
- Resolute (Device) $85.16
- ELIQUIS (Drug) $82.95
- BRILINTA (Drug) $70.38
- INJECTAFER (Drug) $68.61
- Corlanor (Drug) $50.29
- Repatha (Biological) $50.08
- Assurity Pacemaker (Device) $50.05
- ONPATTRO (Drug) $48.38
- Pacemakers (Device) $48.28
- Claria MRI (Device) $47.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Frederick
Dr. Stephen Williams, M.d., M.p.h, M.D., M.P.H
Cardiovascular Disease — Payments: $71,640
Cardiovascular Disease $71,640
Kusay Barakat, M.d, M.D
Cardiovascular Disease — Payments: $19,947
Cardiovascular Disease $19,947
Chen Tung, Md, MD
Cardiovascular Disease — Payments: $7,376
Cardiovascular Disease $7,376
Shawn Buki, Md, MD
Cardiovascular Disease — Payments: $5,874
Cardiovascular Disease $5,874
Dr. Samir Ahuja, M.d, M.D
Cardiovascular Disease — Payments: $4,749
Cardiovascular Disease $4,749
Dr. John Vitarello, M.d, M.D
Cardiovascular Disease — Payments: $3,956
Cardiovascular Disease $3,956